Leniolisib (phosphate)
Leniolisib (CDZ173) phosphate is a potent and selective PI3Kδ inhibitor. Leniolisib phosphate has the potential for immunodeficiency disorders treatment.
Product Specifications
CAS Number
1354691-97-6
Product Name Alternative
CDZ173 (phosphate)
UNSPSC
12352005
Target
PI3K
Type
Reference compound
Related Pathways
PI3K/Akt/mTOR
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/leniolisib-phosphate.html
Purity
99.10
Solubility
DMSO : 100 mg/mL (ultrasonic) |H2O : 100 mg/mL (ultrasonic)
Smiles
CCC(N1C[C@H](CC1)NC2=C3CN(CCC3=NC=N2)C4=CC(C(F)(F)F)=C(N=C4)OC)=O.O=P(O)(O)O
Molecular Formula
C21H28F3N6O6P
Molecular Weight
548.45
References & Citations
[1]Rao V, et al. Effective 'Activated PI3Kd Syndrome' -targeted therapy with PI3Kd inhibitor leniolisib. The New England journal of medicine: NEJM. ISSN 0028-4793; 1533-4406|[2]Hoegenauer K, et al. Discovery of CDZ173 (Leniolisib), Representing a Structurally Novel Class of PI3K Delta-Selective Inhibitors. ACS Med Chem Lett. 2017 Aug 25;8 (9) :975-980.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C (Powder, sealed storage, away from moisture)
Scientific Category
Reference compound1
Clinical Information
Launched
Isoform
PI3Kα; PI3Kβ; PI3Kγ; PI3Kδ
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
208067 100 µg
Cebpz (AI848081, Cbf, CBF2, CCAAT/enhancer binding protein alpha (C/EBP) related sequence 1, CCAAT/enhancer binding protein zeta, CCAAT-binding factor, CCAAT-box-binding transcription factor, Cebpa-rs1)
Sign In for Pricing
View Details K6280004 1.0 µg DNA
Vom1r41 sgRNA CRISPR Lentivector (Rat) (Target 3)
Sign In for Pricing
View Details